Chong Kun Dang Holdings Corp. (KRX:001630)
South Korea · Delayed Price · Currency is KRW 38,650
-350 (-0.90%)
Aug 21, 2026, 3:30 PM KST
Chong Kun Dang Holdings Market Cap
Chong Kun Dang Holdings has a market cap or net worth of 184 billion as of August 21, 2026. Its market cap has decreased by -17.68% in one year.
Market Cap
184.00B
Enterprise Value
910.33B
Revenue
961.64B
Ranking
n/a
PE Ratio
3.54
Stock Price
38,650.00
ChartMarket Cap Chart
Since July 9, 1992, Chong Kun Dang Holdings's market cap has increased from 43.10B to 184.00B, an increase of 326.88%. That is a compound annual growth rate of 4.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 184.00B | -16.43% |
| Dec 30, 2025 | 220.18B | -3.04% |
| Dec 30, 2024 | 227.08B | -19.63% |
| Dec 28, 2023 | 282.55B | 9.42% |
| Dec 29, 2022 | 258.23B | -31.93% |
| Dec 30, 2021 | 379.33B | -40.61% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 218.19B |
| Yungjin Pharm. | 217.09B |
| AptaBio Therapeutics | 191.04B |
| REYON Pharmaceutical | 183.41B |
| Whan In Pharm | 181.88B |
| FutureChem Co.,Ltd | 181.62B |
| JW Lifescience | 171.72B |
| Daewon Pharmaceutical | 165.25B |